Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Exam Prep1
- Article Type
- Comparative Study1
- English Abstract1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Rev Clin Esp1
Search Results
Sort by
- BookFrancis P. Worden, MD, RPh, Professor, Division of Hematology/Oncology, ... Show More Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, Anthony J. Perissinotti, PharmD, BCOP, Clinical Pharmacist Specialist, Inpatient Hematology, Department of Pharmacy, University of Michigan Health Services, Ann Arbor, Michigan, Bernard L .Marini, PharmD, Clinical Pharmacist Specialist, Inpatient Hematology, Department of Pharmacy, University of Michigan Health Services, Ann Arbor, Michigan.Contents:
Microtubule inhibitors
Alkylating agents
Enzyme inhibitors : topoisomerase I inhibitors
Enzyme inhibitors : topoisomerase II inhibitors
Antimetabolites
Monoclonal antibodies
VEGF trap
Tyrosine kinase inhibitors
Anti-androgen therapies
Mammalian target of rapamycin (MTOR) inhibitors
Histone deacetylase (HDAC) inhibitors
Hypomethylating agents
Proteasome inhibitors
Immunomodulatory agents
L-asparaginase enzymes
Promyelocytic leukemia gene retinoic acid receptor-alpha (PMI-RARA)translocation inhibitors
Sipuleucel-T(Provenge®)
Omacetaxine (Synribo®)
Estramustine (Emcyt®).Digital Access Ovid 2016 - ArticleCasado S, Plaza JJ, Matesanz R, Nuño J, Egido J, Hernando L.Rev Clin Esp. 1977 Oct 15;147(1):27-30.